Endometriosis
Conditions
Interventions
Medicine group (Endometriosis-related medicine):None
Surgery Group (Surgery ± Postsurgical Medicine):None
Sponsors
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) Informed consent has been signed (2) Women of childbearing age: 20-45 years old (3) Clinical diagnosis (symptoms, gynecological examination, ultrasound and/or MRI) or biopsy pathological diagnosis (4) Exclude contraindications to estrogen and progesterone drugs
Exclusion criteria
Exclusion criteria: (1) Patients who participate in other interventional research projects in addition to routine clinical diagnosis and treatment (2) Patients with poor living conditions, incapacitation or loss of consciousness. (3) The investigator believes that it is not suitable to participate in this study. (4) Patients with complete obstructive intestinal heterogeneity. (5) Previous history of severe liver disease (6) Patients with combined or diagnosed malignant tumors (7) Patients with other intestinal diseases (such as inflammatory bowel disease, familial adenomatous polyposis, etc.) or patients with a history of intestinal surgery (8) Combined with diseases that may affect intestinal function or taking related drugs (such as aminosalicylic acid preparations, thiopurines, glucocorticoids, etc.) within 3 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-related quality of life;patient global impression of change;Direct economic costs; | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy;Recurrence;Pain (Dysmenorrhea, dyspareunia, non-cyclic pelvic pain);gastrointestinal quality of life;Urinary symptoms; | — |
Countries
China
Contacts
Public ContactYi Dai
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed